Kilitch Drugs (India) Limited has informed the Exchange about Copy of Newspaper Publication
KILITCH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Kilitch Drugs (India) Limited has submitted copies of newspaper advertisements published on July 18, 2025, in compliance with SEBI ICDR Regulations regarding its proposed Rights Issue. The company is issuing 13,98,463 fully paid-up equity shares of face value Rs. 10 each at a price of Rs. 357 per share (including Rs. 347 premium), aggregating to Rs. 4,992.51 lakhs. The ratio is 2 Rights Equity Shares for every 23 shares held, with the record date set as July 15, 2025. The issue opens on July 23, 2025, and closes on August 21, 2025. Five specific investors have committed to subscribing 10,00,000 shares (Rs. 3,570 lakhs) in aggregate. The Letter of Offer was approved by the Board on July 12, 2025.
This is an informational filing about the mandatory newspaper publication for the ongoing Rights Issue — no new financial decision is being announced. Existing eligible shareholders now need to decide whether to subscribe, renounce, or let their rights entitlements lapse by the August 21, 2025 closing date. Successful full subscription would raise about Rs. 49.9 crore for the company, potentially leading to share dilution of roughly 8.7%.